Cargando…
Advances in pancreatic cancer biomarkers
Biomarkers play an essential role in the management of patients with invasive cancers. Pancreatic ductal adenocarcinoma (PDC) associated with poor prognosis due to advanced presentation and limited therapeutic options. This is further complicated by absence of validated screening and predictive biom...
Autores principales: | Hasan, Syed, Jacob, Rojymon, Manne, Upender, Paluri, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478006/ https://www.ncbi.nlm.nih.gov/pubmed/31044028 http://dx.doi.org/10.4081/oncol.2019.410 |
Ejemplares similares
-
Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis
por: Paluri, Ravi Kumar, et al.
Publicado: (2023) -
Therapeutic options for ampullary carcinomas. A review
por: Regalla, Dileep Kumar Reddy, et al.
Publicado: (2019) -
The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience
por: Manne, Ashish, et al.
Publicado: (2020) -
Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
por: Paluri, Ravi K., et al.
Publicado: (2019) -
Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence
por: Manne, Ashish, et al.
Publicado: (2023)